Related Experiment Videos
Alzheimer's disease: a challenging enigma
Archives of Pathology & Laboratory Medicine
|April 1, 1982
Summary
Senile dementia of the Alzheimer type (SDAT) involves significant brain lesions and nerve cell loss, differing quantitatively from normal aging. Current treatments targeting cholinergic neurons have been unsuccessful, necessitating further research into SDAT
Area of Science:
- Neuropathology
- Neuroscience
- Gerontology
Background:
- Senile dementia of the Alzheimer type (SDAT) is characterized by severe histopathologic lesions in gray matter.
- Key lesions include neurofibrillary tangles, neuritic plaques, granulovacuolar degeneration, Hirano bodies, and neuronal loss.
- The distinction between SDAT and normal brain aging is primarily quantitative.
Purpose of the Study:
- To investigate the pathogenesis of Alzheimer type dementia.
- To understand the neurochemical underpinnings of the disease, particularly cholinergic neuron involvement.
- To highlight the need for improved animal models and clinicopathologic studies.
Main Methods:
- Histopathologic examination of brain tissue from deceased patients.
- Neurochemical analyses to identify affected neuronal systems.
- Review of existing theories on SDAT etiology (genetics, toxins, viruses).
Main Results:
- SDAT brains exhibit significant neuropathologic changes compared to normal aging.
- Evidence suggests a particular vulnerability of cholinergic neurons in SDAT.
- Clinical trials using choline precursors have not yielded successful outcomes.
Conclusions:
- Alzheimer type dementia involves distinct and severe neuropathologic alterations.
- Further clinicopathologic research, potentially utilizing autopsy tissues, is crucial for understanding SDAT pathogenesis.
- The lack of a satisfactory animal model impedes progress in developing effective treatments.